Daiwa Securities Group’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
BBA
Daiwa Securities Group's PRAX Position: Q3 2026 in Review
Daiwa Securities Group increased its Praxis Precision Medicines (PRAX) stake by 177% in Q3 2026, buying an estimated $673K and bringing the position to 3,184 shares worth $927K. The position accounts for ﹤0.01% of the portfolio, ranked #845.
Daiwa Securities Group first reported a position in PRAX in Q4 2021 and has held it in 12 quarters since. 339 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.
- Daiwa Securities Group held 3,184 shares of Praxis Precision Medicines worth $927K as of Q3 2026.
- Daiwa Securities Group bought 2,033 Praxis Precision Medicines shares in Q3 2026, an estimated $673K.
- Praxis Precision Medicines made up ﹤0.01% of Daiwa Securities Group's portfolio in Q3 2026, its #845 holding.
- Daiwa Securities Group first reported a position in Praxis Precision Medicines in Q4 2021 and has held it in 12 quarters since.
- 339 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.
Based on Daiwa Securities Group's 13F filing for Q3 2026, filed 29 Oct 2026.